Lipid-based novel formulations are advancing menopause management
Arun Kedia, Managing Director, VAV Lipids
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Orchid Pharma, Cipla to launch antibiotic Cefepime-Enmetazobactam in India
This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…
IPA hosts Global Pharmaceutical Quality Summit 2024
Global quality experts call for strengthening quality culture and leveraging technological advancements
10th edition of PharmaLytica held in Hyderabad
PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and…
Revised Schedule M audits to test will, skill of regulators and regulated
As the US FDA raises quality expectations, investigations into its inspection practices are being closely watched by biopharma…
Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari
Exports are being made, particularly to the EU, UAE, and Japan, while other markets like Malaysia, Southeast Asia, and Taiwan are…
Alzheimer’s drug Leqembi launched by Eisai, Biogen in China
China is the third country to launch LEQEMBI following the US and Japan
Osteoporosis market to reach $17.9 bn across 7MM in 2033: GlobalData
With longer lifespans, its prevalence is expected to rise, necessitating a greater focus on bone health management and proactive…
US lawmakers question FDAs drug inspection programme in India and China
The lawmakers wrote that theinspection outcomes were the opposite of what would be expected given the poor quality control and…
Lupin receives tentative approval for Olopatadine Hydrochloride Ophthalmic Solution
The drug is a generic equivalent of Pataday Once Daily Relief, 0.7 per cent (OTC)